Literature DB >> 16103554

Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease.

T Nageh1, R A Sherwood, B M Harris, M R Thomas.   

Abstract

OBJECTIVE: To assess the role of cardiac troponin I (cTnI) in predicting outcome after percutaneous coronary intervention (PCI). METHODS AND
RESULTS: cTnI was measured immediately before and at 6, 14, and 24 hours after PCI in 316 consecutive patients with stable symptoms and native coronary artery disease. The study end point was the occurrence of major adverse cardiac events (MACE) at 30 days and at 18 months after PCI: death, Q wave myocardial infarction (MI), or repeat revascularisation in hospital. Postprocedural cTnI increased in 31% of patients. The cumulative MACE rate at 18 months was 25% (17.7% due to repeat PCI procedures). There was a significant association between postprocedural cTnI increase and death, Q wave MI, or both (odds ratio (OR) 3.28, 95% confidence interval (CI) 1.7 to 6.4, p = 0.01). Post-PCI cTnI increase had a positive predictive value (PPV) for adverse events at 18 months of 0.47 and a negative predictive value (NPV) of 0.96 (OR 18.9, 95% CI 9.7 to 37, p < 0.0001). The presence of both a postprocedural cTnI rise and a procedural angiographic complication gave a PPV for adverse events of 0.69 and an NPV of 0.92 (OR 22.6, 95% CI 2.6 to 68.6, p = 0.0005).
CONCLUSIONS: cTnI increased post-procedurally in one third of this stable patient population undergoing elective PCI and was independently and significantly predictive of an increased risk of adverse events at 18 months, predominantly in the form of repeat PCI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103554      PMCID: PMC1769083          DOI: 10.1136/hrt.2004.042911

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  27 in total

1.  Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina.

Authors:  M Galvani; F Ottani; D Ferrini; J H Ladenson; A Destro; D Baccos; F Rusticali; A S Jaffe
Journal:  Circulation       Date:  1997-04-15       Impact factor: 29.690

2.  Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group.

Authors:  B Lindahl; P Venge; L Wallentin
Journal:  Circulation       Date:  1996-05-01       Impact factor: 29.690

3.  Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia.

Authors:  M S Lüscher; K Thygesen; J Ravkilde; L Heickendorff
Journal:  Circulation       Date:  1997-10-21       Impact factor: 29.690

4.  Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention.

Authors:  A Kini; J D Marmur; S Kini; G Dangas; T P Cocke; S Wallenstein; E Brown; J A Ambrose; S K Sharma
Journal:  J Am Coll Cardiol       Date:  1999-09       Impact factor: 24.094

5.  Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization.

Authors:  A H Wu; Y J Feng; R Moore; F S Apple; P H McPherson; K F Buechler; G Bodor
Journal:  Clin Chem       Date:  1998-06       Impact factor: 8.327

6.  Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions.

Authors:  A E Abdelmeguid; E J Topol; P L Whitlow; S K Sapp; S G Ellis
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

7.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

Authors:  E M Antman; M J Tanasijevic; B Thompson; M Schactman; C H McCabe; C P Cannon; G A Fischer; A Y Fung; C Thompson; D Wybenga; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245

8.  Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators.

Authors:  E M Ohman; P W Armstrong; R H Christenson; C B Granger; H A Katus; C W Hamm; M A O'Hanesian; G S Wagner; N S Kleiman; F E Harrell; R M Califf; E J Topol
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245

9.  Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience.

Authors:  K Tan; N Sulke; N Taub; E Sowton
Journal:  J Am Coll Cardiol       Date:  1995-03-15       Impact factor: 24.094

10.  Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

Authors: 
Journal:  Lancet       Date:  1998-07-11       Impact factor: 79.321

View more
  11 in total

1.  Frequency, risk factors, and effect on long-term survival of increased troponin I following uncomplicated elective percutaneous coronary intervention.

Authors:  Henry S Loeb; Jayson C Liu
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

Review 2.  Is periprocedural CK-MB a better indicator of prognosis after emergency and elective percutaneous coronary intervention compared with post-procedural cardiac troponins?

Authors:  Nicholas D Gollop; Anumita Dhullipala; Nalin Nagrath; Phyo K Myint
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-09

Review 3.  The evolving role of cardiac troponin in the evaluation of cardiac disorders.

Authors:  Paul Anaya; David J Moliterno
Journal:  Curr Cardiol Rep       Date:  2013-11       Impact factor: 2.931

4.  Troponin T elevation and prognosis after multivessel compared with single-vessel elective percutaneous coronary intervention.

Authors:  M B Nienhuis; J P Ottervanger; J-H E Dambrink; L D Dikkeschei; H Suryapranata; A W J van 't Hof; J C A Hoorntje; M J de Boer; A T M Gosselink; F Zijlstra
Journal:  Neth Heart J       Date:  2007-05       Impact factor: 2.380

5.  Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).

Authors:  Issam D Moussa; Lloyd W Klein; Binita Shah; Roxana Mehran; Michael J Mack; Emmanouil S Brilakis; John P Reilly; Gilbert Zoghbi; Elizabeth Holper; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2013-10-22       Impact factor: 24.094

6.  Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention.

Authors:  Vimal Mehta; Rishi Sukhija; Pratishtha Mehra; Anuj Goyal; Jamal Yusuf; Bhawna Mahajan; V K Gupta; Sanjay Tyagi; Chandrasekar Palaniswamy; Wilbert S Aronow
Journal:  Indian Heart J       Date:  2016-01-18

7.  Rise of serum troponin levels following uncomplicated elective percutaneous coronary interventions in patients without clinical and procedural signs suggestive of myocardial necrosis.

Authors:  Ali Buturak; Aleks Degirmencioglu; Ozgur Surgit; Ali Rıza Demir; Huseyin Karakurt; Mehmet Erturk; Selcuk Yazıcı; Mustafa Serteser; Tugrul Norgaz; Sevket Gorgulu
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-02-11       Impact factor: 1.426

Review 8.  Effect of Remote Ischemic Preconditioning on Perioperative Cardiac Events in Patients Undergoing Elective Percutaneous Coronary Intervention: A Meta-Analysis of 16 Randomized Trials.

Authors:  Xiangming Wang; Na Kong; Chuanwei Zhou; Deeraj Mungun; Zakaria Iyan; Yan Guo; Zhijian Yang
Journal:  Cardiol Res Pract       Date:  2017-09-14       Impact factor: 1.866

9.  Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention.

Authors:  Jing Yang; Jidong Zhang; Wei Cui; Fan Liu; Ruiqin Xie; Xiaohong Yang; Guoqiang Gu; Hongmei Zheng; Jingchao Lu; Xiuchun Yang; Guangming Zhang; Qian Wang; Xue Geng
Journal:  Anatol J Cardiol       Date:  2014-04-16       Impact factor: 1.596

10.  Biomarkers and Bioassays for Cardiovascular Diseases: Present and Future.

Authors:  Derek S Sim; Hsiao Lieu; Patrick Andre
Journal:  Biomark Insights       Date:  2008-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.